Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients.
about
Biomarkers for glioma immunotherapy: the next generationVaccine therapies in malignant gliomaTrial watch: Dendritic cell-based anticancer therapyDendritic Cell-Based Immunotherapy Treatment for Glioblastoma MultiformeThe kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy.Immunotherapy in glioblastoma: emerging options in precision medicinePrioritization schema for immunotherapy clinical trials in glioblastoma.Recent advances and future of immunotherapy for glioblastoma.Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.Novel chemotherapeutics and other therapies for treating high-grade glioma.Immunomonitoring in glioma immunotherapy: current status and future perspectives.Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme.The development of dendritic cell vaccine-based immunotherapies for glioblastoma.Implementing liquid biopsies into clinical decision making for cancer immunotherapy.TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination.Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.
P2860
Q26825496-7DDA3FE3-F728-459D-AFF3-C8045F2EDA00Q26829328-2678EE00-3DA4-441D-9B3A-E9DC7694D9B6Q27024047-CE3FCA0E-505C-4EAA-9D1E-9588071CEFA7Q28087485-459B23DD-6634-410C-9986-504EB7D1B5A1Q35994427-4F4D13E8-68A1-44B1-A78E-A9C1887D6B21Q37050960-7D8B4172-4FCB-46E4-91D7-D132240456AEQ37078999-52544075-5859-4349-960F-C4940A724726Q37239071-4CB98003-2247-42A5-A73D-ECA1D9F38FC9Q38526550-6E75FEE9-C784-4721-8BB7-A9CCAC4D524AQ38569802-85D4C40C-4FBB-4F3D-9A29-4715E8B347DCQ38659771-F3DEC5A2-E9AC-4FDF-9E77-566DFC3E6ADAQ38864816-5B4D2E48-F19E-4572-9E65-10301E6F41B8Q38990679-F5FFDD09-10A0-48E3-B95D-9E5441E54912Q39304648-C3405979-38D1-4720-8C6A-B47BB7A08696Q42169344-641182BD-45FC-4D1F-B821-594A4028B2B0Q47325431-AD2F6196-66CA-4D5C-84A0-3A0395327718
P2860
Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cytokine responsiveness of CD8 ...... tion in glioblastoma patients.
@ast
Cytokine responsiveness of CD8 ...... tion in glioblastoma patients.
@en
type
label
Cytokine responsiveness of CD8 ...... tion in glioblastoma patients.
@ast
Cytokine responsiveness of CD8 ...... tion in glioblastoma patients.
@en
prefLabel
Cytokine responsiveness of CD8 ...... tion in glioblastoma patients.
@ast
Cytokine responsiveness of CD8 ...... tion in glioblastoma patients.
@en
P2093
P2860
P50
P356
P1476
Cytokine responsiveness of CD8 ...... ation in glioblastoma patients
@en
P2093
Dominique N Lisiero
Horacio Soto
Michael Safaee
Richard M Jin
Rudi Scharnweber
Xiaoyan Wang
P2860
P2888
P356
10.1186/2051-1426-2-10
P577
2014-05-13T00:00:00Z
P5875
P6179
1041261084